Clinical characteristics and prognosis of patients with retinoblastoma: 8-year follow-up

Background/aim: The aim of this study was to investigate the potential correlation between clinical characteristics and prognosis of patients with retinoblastoma (Rb). Materials and methods: This retrospective study included 314 Rb patients. Clinical data including laterality of eyes, sex, age, presenting signs, lag time, and survival were recorded and analyzed. Results: Leukocoria is the most common clinical presentation of Rb. Patients with isolated leukocoria had shorter lag time and exhibited a high survival rate (85%, 5 years). Patients with strabismus and blurred vision, and who were older and had longer lag time, exhibited an excellent survival rate (100% and 92.3%, respectively, 5 years). Patients with exophthalmos had the longest lag time and the lowest survival rate (17.8%, 5 years). The 5-year survival rate of patients with a lag time of ≤6 months was 84.7%, which was significantly higher than that of patients with a lag time of >6 months (64.7%). Conclusion: Leukocoria, strabismus, and blurred vision are mild clinical manifestations of Rb that are associated with better disease prognosis, whereas exophthalmos is an indicator of poor prognosis. Long lag time is a risk factor for the survival of Rb, which can be avoided. Early detection and treatment can greatly improve the survival of Rb patients.

Clinical characteristics and prognosis of patients with retinoblastoma: 8-year follow-up

Background/aim: The aim of this study was to investigate the potential correlation between clinical characteristics and prognosis of patients with retinoblastoma (Rb). Materials and methods: This retrospective study included 314 Rb patients. Clinical data including laterality of eyes, sex, age, presenting signs, lag time, and survival were recorded and analyzed. Results: Leukocoria is the most common clinical presentation of Rb. Patients with isolated leukocoria had shorter lag time and exhibited a high survival rate (85%, 5 years). Patients with strabismus and blurred vision, and who were older and had longer lag time, exhibited an excellent survival rate (100% and 92.3%, respectively, 5 years). Patients with exophthalmos had the longest lag time and the lowest survival rate (17.8%, 5 years). The 5-year survival rate of patients with a lag time of ≤6 months was 84.7%, which was significantly higher than that of patients with a lag time of >6 months (64.7%). Conclusion: Leukocoria, strabismus, and blurred vision are mild clinical manifestations of Rb that are associated with better disease prognosis, whereas exophthalmos is an indicator of poor prognosis. Long lag time is a risk factor for the survival of Rb, which can be avoided. Early detection and treatment can greatly improve the survival of Rb patients.

___

  • Parkin DM, Stiller CA, Draper GJ. International Incidence of Childhood Cancer. IARC Scientific Publications Number 87. Lyon, France: International Agency for Research on Cancer; 1988.
  • Parkin DM, Kramarova E, Draper GJ. International Incidence of Childhood Cancer Volume 2. IARC Scientific Publications Number 144. Lyon, France: International Agency for Research on Cancer; 1998.
  • Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol 2005; 140: 505–506.
  • Chantada G, Fandiño A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999; 80:171–174.
  • Rodriguez-Galindo C, Wilson M, Chantada G, Fu L, Qaddoumi I, Antoneli C, Leal-Leal C, Sharma T, Barnoya M, Epelman S et al. Retinoblastoma: one world, one vision. Pediatrics 2008; 122: e763–770.
  • Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005; 18: 41–53.
  • Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodríguez-Galindo C,  Schvartzman E et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006; 47: 801–805.
  • Gatta G, Capocaccia R, Coleman MP, Ries LA,  Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002; 95: 1767–1772.
  • Chang CY, Ghiou TJ, Hwang B, Bai LY, Hsu WM, Hsieh YL. Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol 2006; 50: 242–249.
  • Naseripour M, Nazari H, Bakhtiari P, Modarres-Zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol 2009; 93: 28–32.
  • Chantada GL, Dunkel IJ, Qaddoumi I, Antoneli CB, Totah A, Canturk S, Nawaiseh I, Fandiño A, Pífano I, Peksayar G et al. Familial retinoblastoma in developing countries. Pediatr Blood Cancer 2009; 53: 338–342.
  • Bowman RJ, Mafwiri M, Luthert P, Luande J, Wood M. Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer 2008; 50: 160–162.
  • Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodríguez-Galindo C. Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer 2011; 58: 545–550.
  • Ozkan A,  Pazarli H,  Celkan T, Karaman S,  Apak H,  Kaner G,  Uzel O,  Yildiz I. Retinoblastoma  in  Turkey: survival and clinical characteristics 1981–2004. Pediatr Int 2006; 48: 369–373.
  • Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a  Turkish  pediatric oncology center. Pediatr Hematol Oncol 2007; 24: 221–231.
  • Augsburger JJ, Bornfeld N, Giblin M. Malignant intraocular tumors-retinoblastoma. In: Yanoff M, editor. Ophthalmology. 1st ed. St. Louis, MO, USA: Mosby International; 1999. pp. 921–928.
  • Abramson DH, Beaverson K, Sangani P, Vora RA,  Lee TC,  Hochberg HM,  Kirszrot J,  Ranjithan M. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics 2003; 112: 1248–1255.
  • Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics 2002; 109: e45.
  • Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW 3rd. Presenting signs of retinoblastoma. J Pediatr 1998; 132: 505–508.
  • Navo E,  Teplisky D,  Albero R, Fandino AC,  Demirdjian G,  Chantada GL. Clinical presentation of retinoblastoma in a middle-income country. J Pediatr Hematol Oncol 2012; 34: e97–101.
  • Aguirre Neto JC, Antoneli CB, Ribeiro KB, Castilho MS, Novaes PE, Chojniak MM, Arias V. Retinoblastoma in children older than 5 years of age. Pediatr Blood Cancer 2007; 48: 292–295.
  • Abdu L, Malami S. Clinicopathological pattern and management of retinoblastoma in Kano, Nigeria. Ann Afr Med 2011; 10: 214–218.
  • Badthu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, Das H, Sah RP. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Experiment Ophthalmol 2005; 33: 386–389.
  • Bhurgri Y, Muzaffar S, Ahmed R, Ahmed N, Bhurgri H, Usman A, Faridi N, Malik J, Kazi LA, Bashir I et al. Retinoblastoma in Karachi, Pakistan. Asian Pac J Cancer Prev 2004; 5: 159–163.
  • Erwenne  CM, Franco EL. Age and lateness of referral as determinants of extra-ocular  retinoblastoma. Ophthalmic Paediatr Genet 1989; 10: 179–184.
  • Mahoney DH. Retinoblastoma. In: McMillan JA, editor. Oski’s Pediatrics: Principles and Practice. New York, NY, USA: Lippincott Williams & Wilkins; 1999. pp. 1525–1527.
  • Leander C, Fu LC, Peña A, Howard SC,  Rodriguez-Galindo C,  Wilimas JA,  Ribeiro RC,  Haik B. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007; 49: 817–819.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Pharyngeal carriage rate of Neisseria meningitidis before and after theHajj pilgrimage, in Zahedan (southeastern Iran), 2012

Maliheh METANAT, Batool SHARIFI-MOOD, Sara SANEI-MOGHADDAM, Nahid Sepehri RAD

The effectiveness of ultrasound treatment for the management of kneeosteoarthritis: a randomized, placebo-controlled, double-blind study

Serap Kapci YILDIZ, Feyza Ünlü ÖZKAN, İlknur AKTAŞ, Ayşe Duygu ŞİLTE, Meryem Yilmaz KAYSIN, Naciye Bilgin BADUR

The patterns and clinical relevance of contact allergen sensitization in a pediatric population with atopic dermatitis

AYŞEGÜL AKAN, MÜGE TOYRAN, EMİNE VEZİR, DİLEK AZKUR, AYŞENUR KAYA, MUSTAFA ERKOÇOĞLU, ERSOY CİVELEK, EMİNE DİBEK MISIRLIOĞLU, CAN NACİ KOCABAŞ

Histopathological findings obtained from reduction mammoplasty specimens

AYNUR ALBAYRAK, ÇİĞDEM GÜLER MESCİ, GÜLNUR GÜLER

Workplace physical violence, verbal violence, and mobbing experiencedby nurses at a university hospital

Fatma Nur Baran AKSAKAL, Emine Füsun KARAŞAHİN, Asiye Uğraş DİKMEN, Emine AVCI, SEÇİL ÖZKAN

Osteoprotegerin as a marker of atherosclerosis in type 1 and type 2 diabetic patients

Çiğdem ALKAÇ, Burak ALKAÇ, Feray AKBAŞ, Hale ARAL, Yeşim KARAGÖZ, Esma Güldal ALTUNOĞLU

PCR investigation of Panton-Valentine leukocidin, enterotoxin, exfoliative toxin, and agr genes in Staphylococcus aureus strains isolated from psoriasis patients

Jülide Sedef GÖÇMEN, Mukadder KOÇAK, Neriman ŞAHİNER, Zeynep Ceren KARAHAN

Paclitaxel-loaded niosomes for intravenous administration: pharmacokineticsand tissue distribution in rats

ZERRİN SEZGİN BAYINDIR, ARZU BEŞİKCİ, NİLÜFER YÜKSEL

Investigation of the protective effect of erdosteine against cyclosporine-inducedinjury in rat liver with histological and biochemical methods

AHMET NACAR, İHSAN KARABOĞA, HAMZA MALİK OKUYAN, NEBİHAT KAPLAN SEFİL, EMEL NACAR, SEDAT MOTOR, SEÇKİN AKKÜÇÜK, ORHAN VELİ ÖZKAN

The effect of tramadol and tramadol + gabapentin combination in patients with lumbar disc herniation after epidural steroid injection

LÜTFİYE PİRBUDAK, HÜLYA ÇİÇEK, MUSTAFA IŞIK, YASEMİN ZER